I added “AZ01 (Interferon beta 1a – pegylated – bi-weekly or monthly injection) (Allozyne)” to the phase 1 list based on this news article about the successful completion of a phase 1 trial. I’m not really sure how much demand there will be for this drug since Biogen is currently in phase 3 with a very similar drug…oh, and did I mention the 3 approved interferon-beta drugs we already have?
